🔗 Visit the ClinicalTrials.gov page for NCT02044185
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | HMGB1 in cancer: good, bad, or both? | Clin Cancer Res | 2013 | 1.79 |
| 2 | Heparan sulfate, an endogenous TLR4 agonist, promotes acute GVHD after allogeneic stem cell transplantation. | Blood | 2012 | 1.71 |
| 3 | Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma. | Cancer Res | 2012 | 1.61 |
| 4 | Association of HMGB1 polymorphisms with outcome after allogeneic hematopoietic cell transplantation. | Biol Blood Marrow Transplant | 2009 | 0.99 |